Low Bacterial Diet in Patients With Cytopenia

Sponsor
Maastricht University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00367588
Collaborator
(none)
20
1

Study Details

Study Description

Brief Summary

The purpose of this prospective, randomized study was to determine the efficacy of low bacterial diet, in comparison to normal hospital diet, with gut colonization by aerobic Gram negative rods and yeasts as primary endpoint. In addition, the occurrence of infections and the total costs of hospital care were documented, in order to identify potential cost savings by the use of either diet.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Low bacterial diet
N/A

Detailed Description

Patients with hematological malignancies who receive intensive chemotherapy usually develop a period of cytopenia, during which there is an increased risk of infection. Mucositis can also develop in these patients, enabling micro-organisms, belonging to the endogenous intestinal flora, to translocate from the intestine to the lymphoid tissue and blood. Therefore, when mucositis and cytopenia develop simultaneously, the risk of infection increases further. In this regard bloodstream infection by Gram negative rods and yeasts are an important cause of serious infections causing considerable morbidity.

In order to reduce the risk of infection several preventive measures have been adopted. Fundamentally, all of these measures were designed to prevent either acquisition of Gram negative rods or fungal pathogens from the environment, or the translocation of these potential pathogens across the mucosal barrier of the gut. These measures include protective (or reverse) isolation, antibiotic prophylaxis with antibiotics which selectively eradicate the aerobic Gram negative rods and yeasts from the gut flora, and finally the use of low-bacterial diets.

In this prospective, randomized study on the efficacy of low bacterial diet, in comparison to normal hospital diet, gut colonization by aerobic Gram negative rods and yeasts, the occurrence of infections and the total costs of hospital care were chosen as study endpoints.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Low Bacterial Diet in Patients With Cytopenia After Intensive Chemotherapy for Hematological Malignancy: a Study of Efficacy
Study Completion Date :
Jun 1, 2004

Outcome Measures

Primary Outcome Measures

  1. Colonization of the gut by aerobic Gram negative rods and yeasts []

Secondary Outcome Measures

  1. The occurrence of infections []

  2. The total societal costs []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • acute leukemia receiving remission induction chemotherapy

  • receiving antibiotic prophylaxis for cytopenia leukocytes lower than 1000/mm3 in peripheral blood)

  • informed consent

Exclusion Criteria:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Maastricht Maastricht Netherlands 6202 AZ

Sponsors and Collaborators

  • Maastricht University Medical Center

Investigators

  • Principal Investigator: Frank H. van Tiel, MD, PhD, University Hospital Maastricht, Maastricht, the Netherlands

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00367588
Other Study ID Numbers:
  • TN3 / CvZ nr.01111
First Posted:
Aug 23, 2006
Last Update Posted:
Oct 25, 2016
Last Verified:
Jun 1, 2004

Study Results

No Results Posted as of Oct 25, 2016